Sevista Tablets contain Ormeloxifene, also known as Centchroman, a selective estrogen receptor modulator (SERM) used primarily as a non-hormonal oral contraceptive and for managing menstrual disorders such as dysfunctional uterine bleeding. It works by altering the estrogen receptor activity in reproductive tissues to prevent pregnancy and regulate menstrual cycles.

• Effective non-hormonal contraceptive with once- or twice-weekly dosing

• Helps control heavy or irregular menstrual bleeding

• Reduces risk of endometrial hyperplasia

• Minimal hormonal side effects compared to traditional contraceptives

• Convenient dosing schedule improves compliance

Sevista is usually taken orally as directed by a healthcare professional. The common regimen involves taking one tablet twice a week for three months, followed by one tablet once a week thereafter. Follow the prescribed schedule carefully for effective contraception and symptom control.

• Initial dose: 60 mg twice weekly (e.g., every 3-4 days) for 12 weeks

• Maintenance dose: 60 mg once weekly after initial period

• Continue treatment as advised by your doctor for contraception or menstrual regulation

• Do not alter the dosing schedule without medical advice

• Not recommended for patients with history of blood clots, liver disease, or hormone-sensitive cancers

• Inform your doctor if you have any cardiovascular diseases or unexplained vaginal bleeding

• Use caution if breastfeeding, and only under medical supervision

• Not suitable for use during pregnancy

• Report any unusual symptoms to your healthcare provider promptly

Common side effects may include:

• Mild gastrointestinal discomfort

• Headache

• Breast tenderness

• Irregular menstrual spotting or breakthrough bleeding

• Dizziness

Serious side effects are rare but may include:

• Signs of thrombosis (swelling, pain in limbs)

• Severe allergic reactions

Seek immediate medical attention if severe symptoms occur.